In our studies, fibroblast-conditioned medium consistently upregulated PAI1 across all five fibroblast-protected breast cancer cell lines; however, tumor cell PAI1 expression has not been previously studied in the context of HER2 kinase therapy resistance. Here, SERPINE1 is linked to breast carcinoma.